AI assistant
Data Image Corporation — Interim / Quarterly Report 2026
Jul 9, 2026
52303_rns_2026-07-09_3b8beb60-52c3-4920-871e-9d8ea3bdc361.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
Data Image Corporation and Subsidiaries
Consolidated Financial Statements for the Three Months Ended March 31, 2026 and 2025 and Independent Auditors’ Review Report
Independent Auditors' Report
The Board of Directors and Shareholders
Data Image Corporation
Introduction
We have reviewed the accompanying consolidated balance sheets of Data Image Corporation and its subsidiaries, as of March 31, 2026 and 2025, the related consolidated statements of comprehensive income, changes in equity and cash flows for the three months then ended, and the related notes to the consolidated financial statements, including material accounting policy information (collectively referred to as the "consolidated financial statements"). Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34 "Interim Financial Reporting" endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China. Our responsibility is to express a conclusion on the consolidated financial statements based on our reviews.
Scope of Review
Except as explained in the following paragraph, we conducted our reviews in accordance with the Standards on Review Engagements of the Republic of China 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of the consolidated financial statements consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Basis for Qualified Conclusion
As disclosed in Note 13 to the consolidated financial statements, the balances of investments accounted for using the equity method as of March 31, 2026 and 2025 were $9,566 thousand and $7,551 thousand (including an investment credit balance of $694 thousand using the equity method), respectively; the net comprehensive income (loss) recognized for the three months ended March 31, 2026 and 2025 were ($169) thousand and ($1,215) thousand, respectively. Information related to the investees as described in Note 33 of the consolidated financial statements was recognized and disclosed based on the investee companies' financial statements for the same periods, which were not reviewed by auditors.
Qualified Conclusion
Based on our reviews, except for adjustments, if any, as might have been determined to be necessary had the financial statements of the non-significant subsidiaries as described in the preceding paragraph been reviewed, nothing has come to our attention that caused us to believe that the consolidated financial statements do not give a true and fair view of the consolidated financial position of Data Image Corporation and its subsidiaries as of March 31, 2026 and 2025, and of its consolidated financial performance and its consolidated cash flows for the three months ended March 31, 2026 and 2025 in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers, and International
- 2 -
Accounting Standard 34 “Interim Financial Reporting” endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China.
The engagement partners on the reviews resulting in this independent auditors’ review report are Chih-Ming Shao and Kuo-Ning Huang.
Deloitte & Touche
Taipei, Taiwan
Republic of China
May 5, 2026
Notice to Readers
The accompanying consolidated financial statements are intended only to present the consolidated financial position, financial performance and cash flows in accordance with accounting principles and practices generally accepted in the Republic of China and not those of any other jurisdictions. The standards, procedures and practices to audit such consolidated financial statements are those generally applied in the Republic of China.
For the convenience of readers, the independent auditors’ report and the accompanying consolidated financial statements have been translated into English from the original Chinese version prepared and used in the Republic of China. If there is any conflict between the English version and the original Chinese version or any difference in the interpretation of the two versions, the Chinese-language independent auditors’ report and consolidated financial statements shall prevail.
- 3 -
Data Image Corporation and Its Subsidiaries
Consolidated Balance Sheets
March 31, 2026, December 31 and March 31, 2025
(In Thousands of New Taiwan Dollars)
| Assets | March 31, 2026 | December 31, 2025 | March 31, 2025 | |||
| Amount | % | Amount | % | Amount | % | |
| Current assets | ||||||
| Cash and cash equivalents (Note 6) | $ 992,295 | 27 | $ 1,024,524 | 28 | $ 1,365,282 | 36 |
| Financial assets at fair value through profit or loss - Current (Note 7) | 41 | - | 140 | - | - | - |
| Accounts receivable (Notes 10 and 24) | 701,802 | 19 | 713,808 | 19 | 661,947 | 17 |
| Accounts receivable from related parties (Notes 24 and 30) | 22,181 | 1 | 27,088 | 1 | 26,569 | 1 |
| Other receivables (Note 10) | 18,048 | - | 21,998 | 1 | 13,253 | - |
| Other receivables from related parties (Note 30) | 13,449 | - | 10,544 | - | 11,385 | - |
| Current tax assets | 2,695 | - | 2,632 | - | 1,013 | - |
| Inventories (Note 11) | 776,101 | 21 | 679,423 | 18 | 565,861 | 15 |
| Other current assets (Notes 18 and 30) | 54,842 | 1 | 62,409 | 2 | 31,491 | 1 |
| Total current assets | 2,581,454 | 69 | 2,542,566 | 69 | 2,676,801 | 70 |
| Non-current assets | ||||||
| Financial assets at fair value through other comprehensive income - Non-current (Note 8) | 4,294 | - | 5,550 | - | 5,719 | - |
| Financial assets at amortized cost - non-current (Notes 9 and 31) | 1,054 | - | 1,054 | - | - | - |
| Investments accounted for using the equity method (Note 13) | 9,566 | - | 9,630 | - | 8,245 | - |
| Property, plant and equipment (Note 14) | 776,439 | 21 | 769,579 | 21 | 775,402 | 20 |
| Right-of-use assets (Notes 15 and 30) | 48,450 | 1 | 51,784 | 1 | 48,667 | 1 |
| Goodwill (Note 16) | 164,826 | 5 | 164,826 | 5 | 164,826 | 4 |
| Intangible assets (Note 17) | 33,769 | 1 | 38,697 | 1 | 51,053 | 2 |
| Deferred tax assets | 55,640 | 2 | 55,060 | 2 | 54,277 | 2 |
| Net defined benefit assets - non-current (Note 22) | 6,152 | - | 6,012 | - | 4,448 | - |
| Other non-current assets (Notes 18 and 30) | 34,353 | 1 | 34,852 | 1 | 23,883 | 1 |
| Total current assets | 1,134,543 | 31 | 1,137,044 | 31 | 1,136,520 | 30 |
| Total assets | $ 3,715,997 | 100 | $ 3,679,610 | 100 | $ 3,813,321 | 100 |
| Liabilities and equity | ||||||
| Current liabilities | ||||||
| Short-term borrowings (Note 19) | $ 37,059 | 1 | $ 35,962 | 1 | $ 45,787 | 1 |
| Financial liabilities at fair value through profit or loss - Current (Note 7) | 3,026 | - | 2,077 | - | 4,019 | - |
| Contract liabilities - Current (Notes 24 and 30) | 45,857 | 1 | 45,740 | 1 | 98,714 | 3 |
| Accounts payable (Note 20) | 490,457 | 13 | 519,355 | 14 | 399,568 | 11 |
| Accounts payable from related parties (Note 30) | 13,928 | - | 8,835 | - | 5,844 | - |
| Other payables (Note 21) | 415,015 | 11 | 225,801 | 6 | 409,280 | 11 |
| Other payables from related parties (Note 30) | 196,213 | 5 | 96,662 | 3 | 132,967 | 4 |
| Current tax liabilities | 59,325 | 2 | 56,690 | 2 | 69,384 | 2 |
| Provisions - Current | 19,821 | 1 | 18,698 | - | 16,206 | - |
| Lease liabilities - Current (Notes 15 and 30) | 13,296 | - | 13,845 | - | 10,812 | - |
| Other current liabilities | 14,410 | 1 | 19,320 | 1 | 14,428 | - |
| Total current liabilities | 1,308,407 | 35 | 1,042,985 | 28 | 1,207,009 | 32 |
| Non-current liabilities | ||||||
| Deferred tax liabilities | 38,088 | 1 | 38,535 | 1 | 40,977 | 1 |
| Lease liabilities - Non-current (Notes 15 and 30) | 26,966 | 1 | 29,689 | 1 | 29,215 | 1 |
| Guarantee deposits received | 93 | - | 90 | - | 489 | - |
| Other non-current liabilities (Note 13) | - | - | - | - | 694 | - |
| Total non-current liabilities | 65,147 | 2 | 68,314 | 2 | 71,375 | 2 |
| Total liabilities | 1,373,554 | 37 | 1,111,299 | 30 | 1,278,384 | 34 |
| Equity attributable to owners of the Company | ||||||
| Share capital | 750,996 | 20 | 750,996 | 20 | 780,996 | 20 |
| Capital surplus | 462,069 | 13 | 462,069 | 13 | 480,527 | 13 |
| Retained earnings | ||||||
| Legal reserve | 186,918 | 5 | 186,918 | 5 | 164,945 | 4 |
| Special reserves | 8,278 | - | 8,278 | - | 26,854 | 1 |
| Unappropriated earnings | 189,709 | 5 | 369,973 | 10 | 316,431 | 8 |
| Total retained earnings | 384,905 | 10 | 565,169 | 15 | 508,230 | 13 |
| Other equity | 11,120 | - | (5,534) | - | 2,177 | - |
| Total equity attributable to owners of the Company | 1,609,090 | 43 | 1,772,700 | 48 | 1,771,930 | 46 |
| Non-controlling interests | 733,353 | 20 | 795,611 | 22 | 763,007 | 20 |
| Total equity | 2,342,443 | 63 | 2,568,311 | 70 | 2,534,937 | 66 |
| Total liabilities and equity | $ 3,715,997 | 100 | $ 3,679,610 | 100 | $ 3,813,321 | 100 |
The accompanying notes are an integral part of the consolidated financial statements.
^{}[] Data Image Corporation and Its Subsidiaries
^{}[] Consolidated Statements of Comprehensive Income
^{}[] For the Three Months Ended March 31, 2026 and 2025
^{}[] (In Thousands of New Taiwan Dollars; Except Earnings Per Share)
| For the Three Months Ended March 31 | ||||
| 2026 | 2025 | |||
| Amount | % | Amount | % | |
| Operating revenue (Notes 24 and 30) | $ 869,660 | 100 | $ 816,384 | 100 |
| Operating costs (Notes 11, 17, 25, and 30) | 671,293 | 77 | 608,113 | 74 |
| Gross profit | 198,367 | 23 | 208,271 | 26 |
| Unrealized gain on transactions | - | - | (475) | - |
| Realized gain on transactions | 105 | - | - | - |
| Realized gross profit | 198,472 | 23 | 207,796 | 26 |
| Operating expenses (Notes 17, 25, and 30) | ||||
| Selling expenses | 29,274 | 3 | 28,079 | 4 |
| General and administrative expenses | 58,150 | 7 | 56,579 | 7 |
| Research and development expenses | 55,532 | 6 | 51,637 | 6 |
| Expected credit gain | (3,492) | - | (124) | - |
| Total operating expenses | 139,464 | 16 | 136,171 | 17 |
| Operating income | 59,008 | 7 | 71,625 | 9 |
| Non-operating income and expenses (Notes 25 and 30) | ||||
| Interest income | 1,755 | - | 2,067 | - |
| Other income | 340 | - | 2,944 | - |
| Other gains and losses | 928 | - | (1,567) | - |
| Finance cost | (677) | - | (616) | - |
| Share of profit or loss of associates | (370) | - | (1,351) | - |
| Total non-operating income and expenses | 1,976 | - | 1,477 | - |
| Income before income tax | 60,984 | 7 | 73,102 | 9 |
| Income tax expenses (Note 26) | 3,073 | - | 16,135 | 2 |
| Net income | 57,911 | 7 | 56,967 | 7 |
(Continued)
- 5 -
^{}[] Data Image Corporation and Its Subsidiaries
^{}[] Consolidated Statements of Comprehensive Income
^{}[] For the Three Months Ended March 31, 2026 and 2025
^{}[] (In Thousands of New Taiwan Dollars; Except Earnings Per Share)
| For the Three Months Ended March 31 | ||||
| 2026 | 2025 | |||
| Amount | % | Amount | % | |
| Other comprehensive income (Note 23) | ||||
| Items that will not be reclassified subsequently to profit or loss | ||||
| Unrealized gains(losses) on investments in equity instruments at fair value through other comprehensive income | $ (1,256) | - | $ 687 | - |
| Items that may be reclassified subsequently to profit or loss: | ||||
| Exchange differences on translation of financial statements of foreign operations | 17,365 | 2 | 10,407 | 1 |
| Share of the other comprehensive income (loss) of associates accounted for using the equity method | 201 | - | 136 | - |
| Other comprehensive income (loss), net of income tax | 16,310 | 2 | 11,230 | 1 |
| Total comprehensive income | $ 74,221 | 9 | $ 68,197 | 8 |
| Net income attributable to: | ||||
| Owners of the Company | $ 45,035 | 5 | $ 44,023 | 5 |
| Non-controlling interests | 12,876 | 2 | 12,944 | 2 |
| $ 57,911 | 7 | $ 56,967 | 7 | |
| Total comprehensive income attributable to: | ||||
| Owners of the Company | $ 61,689 | 7 | $ 54,478 | 6 |
| Non-controlling interests | 12,532 | 2 | 13,719 | 2 |
| $ 74,221 | 9 | $ 68,197 | 8 | |
| Earnings per share (Note 27) | ||||
| Basic earnings per share | $ 0.60 | $ 0.56 | ||
| Diluted earnings per share | $ 0.60 | $ 0.56 | ||
The accompanying notes are an integral part of the consolidated financial statements.
- 6 -
Data Image Corporation and Its Subsidiaries
Consolidated Statement of Changes in Equity
For the Three Months Ended March 31, 2026 and 2025
(In Thousands of New Taiwan Dollars)
| Equity Attributable to Owners of the Company | ||||||||||
| Share Capital (Note 22) | Capital Surplus (Notes 22 and 27) | Retained Earnings (Note 22) | Other equity (Note 22) | Total | Non-Controlling Interests (Note 22) | Total Equity | ||||
| Legal Reserve | Special Reserves | Unappropriated Earnings | Exchange Differences on Translation of the Financial Statements of Foreign Operations | Unrealized Valuation Gain (Loss) on Financial Assets at Fair Value through Other Comprehensive Income | ||||||
| Balance on January 1, 2025 | $ 780,996 | $ 480,527 | $ 164,945 | $ 26,854 | $ 506,707 | $(8,551) | $ 273 | $1,951,751 | $ 824,078 | $2,775,829 |
| Appropriation of 2024 earnings: Cash dividends distributed by the Company | - | - | - | - | (234,299) | - | - | (234,299) | - | (234,299) |
| Cash dividends distributed by subsidiaries | - | - | - | - | - | - | - | - | (74,790) | (74,790) |
| Net income for the three months ended March 31, 2025 | - | - | - | - | 44,023 | - | - | 44,023 | 12,944 | 56,967 |
| Other comprehensive income for the three months ended March 31, 2025, net of income tax | - | - | - | - | - | 10,206 | 249 | 10,455 | 775 | 11,230 |
| Total comprehensive income for the three months ended March 31, 2025 | - | - | - | - | 44,023 | 10,206 | 249 | 54,478 | 13,719 | 68,197 |
| Balance on March 31, 2025 | $ 780,996 | $ 480,527 | $ 164,945 | $ 26,854 | $ 316,431 | $ 1,655 | $ 522 | $1,771,930 | $ 763,007 | $2,534,937 |
| Balance on January 1, 2026 | $ 750,996 | $ 462,069 | $ 186,918 | $ 8,278 | $ 369,973 | $(5,995) | $ 461 | $1,772,700 | $ 795,611 | $2,568,311 |
| Appropriation of 2025 earnings: Cash dividends distributed by the Company | - | - | - | - | (225,299) | - | - | (225,299) | - | (225,299) |
| Cash dividends distributed by subsidiaries | - | - | - | - | - | - | - | - | (74,790) | (74,790) |
| Net income for the three months ended March 31, 2026 | - | - | - | - | 45,035 | - | - | 45,035 | 12,876 | 57,911 |
| Other comprehensive income for the three months ended March 31, 2026, net of income tax | - | - | - | - | - | 17,109 | (455) | 16,654 | (344) | 16,310 |
| Total comprehensive income for the three months ended March 31, 2026 | - | - | - | - | 45,035 | 17,109 | (455) | 61,689 | 12,532 | 74,221 |
| Balance on March 31, 2026 | $ 750,996 | $ 462,069 | $ 186,918 | $ 8,278 | $ 189,709 | $ 11,114 | $ 6 | $1,609,090 | $ 733,353 | $2,342,443 |
The accompanying notes are an integral part of the consolidated financial statements.
^{}[] Data Image Corporation and Its Subsidiaries
^{}[] Consolidated Statements of Cash Flows
^{}[] For the Three Months Ended March 31, 2026 and 2025
^{}[] (In Thousands of New Taiwan Dollars)
| For the Three Months Ended March 31 | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities | ||
| Income before income tax | $ 60,984 | $ 73,102 |
| Adjustments for: | ||
| Depreciation expenses | 17,192 | 16,523 |
| Amortization expenses | 5,041 | 5,066 |
| Expected credit reversed | (3,492) | (124) |
| Net loss on fair value changes of financial assets and liabilities at fair value through profit or loss | 9,807 | 8,988 |
| Finance cost | 677 | 616 |
| Interest income | (1,755) | (2,067) |
| Share of profit or loss of associates | 370 | 1,351 |
| Loss on disposal of property, plant and equipment | 50 | 65 |
| Write-down of inventories | 3,240 | 891 |
| Unrealized gain on transactions with associates | - | 475 |
| Realized gain on transactions with associates | (105) | - |
| Changes in operating assets and liabilities | ||
| Financial assets mandatorily measured at fair value through profit or loss | (2,336) | 374 |
| Accounts receivable | 15,471 | 22,053 |
| Accounts receivable from related parties | 4,907 | (240) |
| Other receivables | 4,119 | 10,032 |
| Other receivables from related parties | (2,905) | (5,921) |
| Inventories | (99,918) | (24,641) |
| Other current assets | 7,567 | (10,448) |
| Net defined benefit asset | (140) | (129) |
| Financial liabilities held for trading | (6,423) | (9,185) |
| Contract liabilities - Current | 117 | (1,837) |
| Accounts payable | (28,898) | (5,234) |
| Accounts payable from related parties | 5,093 | (2,167) |
| Other payables | (17,771) | (16,090) |
| Other payables from related parties | 6,079 | (775) |
| Provisions | 1,123 | 937 |
| Other current liabilities | (4,910) | 572 |
| Cash (used in) generated from operations | (26,816) | 62,187 |
| Interest received | 1,586 | 1,992 |
| Interest paid | (676) | (616) |
| Income tax paid | (1,528) | (406) |
| Net cash (used in) generated from operating activities | (27,434) | 63,157 |
| Cash flows from investing activities | ||
| Payments for property, plant and equipment and prepayment for equipment | (10,432) | (3,786) |
| Increase in refundable deposits | (84) | (1,509) |
(Continued)
- 8 -
^{}[] - 9 -
Data Image Corporation and Its Subsidiaries
Consolidated Statements of Cash Flows
For the Three Months Ended March 31, 2026 and 2025
(In Thousands of New Taiwan Dollars)
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Decrease in other non-current assets | $ 50 | $ - |
| Net cash used in investing activities | (10,466) | (5,295) |
| Cash flows from financing activities | ||
| Repayment of the principal portion of lease liabilities | (3,272) | (3,363) |
| Net cash used in financing activities | (3,272) | (3,363) |
| Effects of exchange rate changes on the balance of cash held in foreign currencies | 8,943 | 4,984 |
| Net (decrease) increase in cash and cash equivalents | (32,229) | 59,483 |
| Cash and cash equivalents at the beginning of the period | 1,024,524 | 1,305,799 |
| Cash and cash equivalents at the end of the period | $ 992,295 | $ 1,365,282 |
The accompanying notes are an integral part of the consolidated financial statements.
^{}[] Data Image Corporation and Its Subsidiaries
^{}[] Notes to the Consolidated Financial Statements
^{}[] For the Three Months Ended March 31, 2026 and 2025
^{}[] (In Thousands of New Taiwan Dollars, Unless Stated Otherwise)
- General information
Data Image Corporation (the "Company") was approved by the Ministry of Economic Affairs on November 22, 1997 for establishment. Its scope of business is the design, manufacturing, and sales of LCD touch modules and LCD modules.
The Company’s shares have been listed on the Taiwan Stock Exchange (TSE) since March 26, 2024.
The consolidated financial statements are presented in the New Taiwan Dollar, which is the Company's functional currency.
- Date and procedure for approving the financial statements
These consolidated financial statements were approved by the Board on May 5, 2026.
- Application of new, amended and revised standards and interpretations
a. Initial application of the amendments to the International Financial Reporting Standards (IFRS), International Accounting Standards (IAS), IFRIC Interpretations (IFRIC), and SIC Interpretations (SIC) (collectively, the “IFRS Accounting Standards”) endorsed and issued into effect by the Financial Supervisory Commission (FSC)
The initial application of the IFRS Accounting Standards endorsed and issued into effect by the FSC did not result in material changes in the Group's accounting policies and did not have a material impact on the consolidated financial position and consolidated financial performance of the Group.
b. The IFRS Accounting Standards in issue but not yet endorsed and issued into effect by the FSC
| New, Amended and Revised Standards and Interpretations | Effective Date Announced by IASB (Note 1) |
|---|---|
| Amendments to IFRS 10 and IAS 28 “Sale or Contribution of Assets between an Investor and its Associate or Joint Venture” | To be determined by IASB |
| IFRS 18 “Presentation and Disclosure in Financial Statements” | January 1, 2027 (Note 2) |
| IFRS 19 “Subsidiaries without Public Accountability: Disclosures” (including the 2025 amendments to IFRS 19) | January 1, 2027 |
| Amendments to IAS 21 “Translation to a Hyperinflationary Presentation Currency” | January 1, 2027 |
Note 1: Unless stated otherwise, the above IFRS Accounting Standards are effective for annual reporting periods beginning on or after their respective effective dates.
Note 2: On September 25, 2025, the FSC announced that IFRS 18 will take effect starting from January 1, 2028. Domestic entities could elect to apply IFRS 18 for an earlier period after the endorsement of IFRS 18 by the FSC.
- 10 -
^{}[] IFRS 18 "Presentation and Disclosure in Financial Statements" and consequential amendments
IFRS 18 will supersede IAS 1 "Presentation of Financial Statements". The main changes comprise:
1) To classify items of income and expenses presented in the statement of profit or loss into the operating, investing, financing, income taxes and discontinued operations categories, the Group shall assess whether it has specified main business activities of investing in particular types of assets and providing financing to customers.
2) The statement of profit or loss shall present totals and subtotals for operating profit or loss, profit or loss before financing and income taxes and profit or loss.
3) Provides guidance to enhance the requirements of aggregation and disaggregation: The Group shall identify the assets, liabilities, equity, income, expenses and cash flows that arise from individual transactions or other events and shall classify and aggregate them into groups based on shared characteristics, so as to result in the presentation in the primary financial statements of line items that have at least one similar characteristic. The Group shall disaggregate items with dissimilar characteristics in the primary financial statements and in the notes. The Group labels items as "other" only if it cannot find a more informative label.
4) Disclosures on Management-defined Performance Measures (MPMs): When in public communications outside financial statements and communicating to users of financial statements management's view of an aspect of the financial performance of the Group as a whole, the Group shall disclose related information about its MPMs in a single note to the financial statements, including the description of such measures, calculations, reconciliations to the subtotal or total specified by IFRS Accounting Standards and the income tax and non-controlling interests effects of related reconciliation items.
In addition, the following consequential amendments have been made to IAS 7 "Statement of Cash Flows":
1) The Group shall use operating profit or loss as the starting point when presenting cash flows from operating activities under the indirect method.
2) Interest and dividends received by the Group shall be classified as investing activities, while interest and dividends paid shall be classified as financing activities. However, if, after assessment, the Group has a specific main operating activity, it shall determine how to classify dividends received, interest received and interest paid in the statement of cash flows by referring to how it classifies dividend income, interest income and interest expense in the statement of profit or loss. The total of each of these cash flows shall be classified in a single category in the statement of cash flows.
Except for the above impact, as of the date the consolidated financial statements were authorized for issue, the Group is continuously assessing the other impacts of the above amended standards and interpretations on the consolidated financial position and consolidated financial performance and will disclose the relevant impact when the assessment is completed.
4. Summary of material accounting policy information
a. Statement of compliance
These interim consolidated financial statements have been prepared in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and IAS 34 "Interim Financial Reporting" as endorsed and issued into effect by the FSC. Disclosure information included in these interim consolidated financial statements is less than the disclosure information required in a complete set of annual consolidated financial statements.
b. Basis of preparation
The consolidated financial statements have been prepared on the historical cost basis except for financial instruments which are measured at fair value and net defined benefit liabilities which are measured at the present value of the defined benefit obligation less the fair value of plan assets.
The fair value measurements, which are grouped into Levels 1 to 3 based on the degree to which the fair value measurement inputs are observable and based on the significance of the inputs to the fair value measurement in its entirety, are described as follows:
1) Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities;
2) Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for an asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and
3) Level 3 inputs are unobservable inputs for an asset or liability.
c. Basis of consolidation
The consolidated financial statements incorporate the financial statements of the Company and the entities controlled by the Company (i.e., its subsidiaries).
When necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies into line with those of the Group.
All intra-group transactions, balances, income and expenses are eliminated in full upon consolidation. Total comprehensive income of subsidiaries is attributed to the owners of the Company and to the non-controlling interests even if this results in the non-controlling interests having a deficit balance.
See Note 12, Tables 4 and 5 for detailed information on subsidiaries (including percentages of ownership and main businesses).
d. Other material accounting policies
Except for the following, please refer to the consolidated financial statements for the year ended December 31, 2025.
1) Retirement benefits
Pension cost for an interim period is calculated on a year-to-date basis by using the actuarially determined pension cost rate at the end of the prior financial year, adjusted for significant market fluctuations since that time and for significant plan amendments, settlements, or other significant one-off events.
2) Income tax expense
Income tax expense represents the sum of the tax currently payable and deferred tax. Interim period income taxes are assessed on an annual basis and calculated by applying to an interim period's pretax income the tax rate that would be applicable to expected total annual earnings.
- Material accounting judgments and key sources of estimation uncertainty
In the application of the Group's accounting policies, management is required to make judgments, estimations, and assumptions on the carrying amounts of assets and liabilities that are not readily apparent
- 12 -
from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered relevant. Actual results may differ from these estimates.
The material accounting judgments and key sources of estimation uncertainty applied to these consolidated financial statements are consistent with those applied to the consolidated financial statements for the year ended December 31, 2025.
6. Cash and cash equivalents
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
|---|---|---|---|
| Cash on hand and petty cash | $ 164 | $ 162 | $ 156 |
| Checking accounts and demand deposits | 546,731 | 570,762 | 731,526 |
| Cash equivalents | |||
| Time deposits | 445,400 | 453,600 | 633,600 |
| $ 992,295 | $ 1,024,524 | $ 1,365,282 |
7. Financial instruments at fair value through profit or loss
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
|---|---|---|---|
| Financial assets - Current | |||
| Financial assets mandatorily measured as at FVTPL | |||
| Derivative instruments (not under hedge accounting) | |||
| Foreign exchange swap contract (a) | $ 41 | $ 140 | $ - |
| Financial liabilities - Current | |||
| Held for trading | |||
| Derivatives instruments (not under hedge accounting) | |||
| Foreign exchange swap contract (a) | $ 3,022 | $ 2,056 | $ 4,015 |
| Foreign exchange forward contracts (b) | 4 | 21 | 4 |
| $ 3,026 | $ 2,077 | $ 4,019 |
a. At the end of the reporting period, outstanding foreign exchange swap contracts not under hedge accounting were as follows:
March 31, 2026
| Currency | Maturity Date | Contract Amount (In Thousands) | |
|---|---|---|---|
| Sell | USD/NTD | 2026.04.02~2026.04.30 | USD14,300/NTD454,211 |
December 31, 2025
| Currency | Maturity Date | Contract Amount (In Thousands) | |
|---|---|---|---|
| Sell | USD/NTD | 2026.01.02~2026.01.26 | USD12,800/NTD400,205 |
March 31, 2025
| Currency | Maturity Date | Contract Amount (In Thousands) | |
|---|---|---|---|
| Sell | USD/NTD | 2025.04.02~2025.04.25 | USD13,600/NTD446,834 |
The Group entered into foreign exchange swap contracts to manage exposures to exchange rate fluctuations of foreign currency denominated assets and liabilities.
b. At the end of the reporting period, outstanding foreign exchange forward contracts not under hedge accounting were as follows:
March 31, 2026
| Currency | Maturity Date | Contract Amount (In Thousands) | |
|---|---|---|---|
| Sell | USD/RMB | 2026.04.27 | USD400/RMB2,758 |
December 31, 2025
| Currency | Maturity Date | Contract Amount (In Thousands) | |
|---|---|---|---|
| Sell | USD/RMB | 2026.01.30 | USD1,200/RMB8,367 |
March 31, 2025
| Currency | Maturity Date | Contract Amount (In Thousands) | |
|---|---|---|---|
| Sell | RMB/USD | 2025.04.30 | RMB2,898/USD400 |
The Group entered into foreign exchange forward contracts to manage exposures to exchange rate fluctuations of foreign currency denominated assets and liabilities.
- Financial assets at fair value through other comprehensive income
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
|---|---|---|---|
| Non-current | |||
| Investments in equity instruments | |||
| Domestic unlisted shares | $ 4,294 | $ 5,550 | $ 5,719 |
The ordinary shares of Insight Genomics Inc. and Renown Information Technology Corp. are held for medium- to long-term strategic purposes. Accordingly, the management elected to designate these investments at FVTOCI as they believe that recognizing short-term fluctuations in these investments' fair value in profit or loss would not be consistent with the Group's strategy of holding these investments for long-term purposes.
^{}[] - 15 -
9. Financial assets at amortized cost
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| Non-current | |||
| Pledged time deposits | $ 1,054 | $ 1,054 | $ - |
| Gross carrying amount | $ 1,054 | $ 1,054 | $ - |
| Less: Allowance for impairment loss | - | - | - |
| Amortized cost | $ 1,054 | $ 1,054 | $ - |
a. As of March 31, 2026, the interest rate range of pledged time deposits was 1.7% per annum.
b. Refer to Note 31 for information related to the pledged financial assets at amortized cost.
10. Accounts receivable and other receivables
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| Accounts receivable | |||
| At amortized cost | |||
| Gross carrying amount | $ 709,020 | $ 724,491 | $ 664,856 |
| Less: Loss allowance | (7,218) | (10,683) | (2,909) |
| $ 701,802 | $ 713,808 | $ 661,947 | |
| Other receivables | |||
| Business tax refunds receivable | $ 13,581 | $ 12,867 | $ 11,018 |
| Others | 4,467 | 9,131 | 2,235 |
| $ 18,048 | $ 21,998 | $ 13,253 |
a. Accounts receivable
The average credit period of sales of goods is 30 to 230 days from upon shipment or the end of the month. No interest is charged on accounts receivable. In determining the recoverability of accounts receivable, the Group considers any changes in the credit quality of accounts receivable from the original credit granting date to the balance sheet date. For new trading customers, the Group uses publicly available financial information or its own trading records to rate its major customers. The Group's exposure and the credit ratings of its counterparties are continuously monitored and credit exposure is controlled by counterparty limits that are reviewed and approved.
The Group measures the loss allowance for accounts receivable at an amount equal to lifetime ECLs. The expected credit losses on accounts receivable are estimated using a provision matrix prepared by reference to the past default experience of the customer and the customer's current financial position. As the Group's historical credit loss experience does not show significantly different loss patterns for different customer segments, the provision for loss allowance based on past due status is not further distinguished according to the Group's different customer base.
The Group writes off an account receivable when there is evidence indicating that the debtor is in severe financial difficulty and there is no realistic prospect of recovery. For accounts receivable that have been written off, the Group continues to engage in enforcement activity to attempt to recover the receivables due. Where recoveries are made, these are recognized in profit or loss.
The following table details the loss allowance of accounts receivable based on the Group's provision matrix.
March 31, 2026
| Counterparty without Sign of Default | Counterparty with Sign of Default | Tota | |||
| Not Past Due | 1 to 90 Days Past Due | Over 90 Days Past Due | |||
| Expected credit loss rate | 0.0%~85.0% | 0.0%~54.0% | 100.0% | 100.0% | |
| Gross carrying amount | $ 682,504 | $ 21,423 | $ 4,224 | $ 869 | $ 709,020 |
| Loss allowance (Lifetime ECLs) | (1,973) | (152) | (4,224) | (869) | (7,218) |
| Amortized cost | $ 680,531 | $ 21,271 | $ - | $ - | $ 701,802 |
December 31, 2025
| Counterparty without Sign of Default | Counterparty with Sign of Default | Tota | |||
| Not Past Due | 1 to 90 Days Past Due | Over 90 Days Past Due | |||
| Expected credit loss rate | 0.0%~2.0% | 0.0%~54.0% | 100.0% | 100.0% | |
| Gross carrying amount | $ 639,838 | $ 79,553 | $ 4,257 | $ 843 | $ 724,491 |
| Loss allowance (Lifetime ECLs) | (5,184) | (399) | (4,257) | (843) | (10,683) |
| Amortized cost | $ 634,654 | $ 79,154 | $ - | $ - | $ 713,808 |
March 31, 2025
| Counterparty without Sign of Default | Counterparty with Sign of Default | Tota | |||
| Not Past Due | 1 to 90 Days Past Due | Over 90 Days Past Due | |||
| Expected credit loss rate | 0.0%~0.5% | 0.0%~0.5% | 0.0% | 100.0% | |
| Gross carrying amount | $ 641,211 | $ 22,787 | $ - | $ 858 | $ 664,856 |
| Loss allowance (Lifetime ECLs) | (1,938) | (113) | - | (858) | (2,909) |
| Amortized cost | $ 639,273 | $ 22,674 | $ - | $ - | $ 661,947 |
The movements of the loss allowance of accounts receivable were as follows:
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Balance on January 1 | $ 10,683 | $ 3,016 |
| Add: Impairment loss recognized | - | 40 |
| Less: Impairment loss reversed | (3,492) | (164) |
| Foreign exchange gains and losses | 27 | 17 |
| Balance on March 31 | $ 7,218 | $ 2,909 |
b. Other receivables – Others
In determining the recoverability of other receivables, the Group measures the allowance loss of other receivables according to the probability of collection of accounts, and after assessing the debtor's operating conditions and the possibility of recovery of accounts, the accounts that cannot be collected are included in the loss allowance.
^{}[] - 17 -
11. Inventories
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| Raw materials | $ 417,969 | $ 355,226 | $ 318,877 |
| Work in process | 212,051 | 174,063 | 137,025 |
| Finished goods | 133,933 | 137,677 | 86,062 |
| Merchandise | 12,148 | 12,457 | 23,897 |
| $ 776,101 | $ 679,423 | $ 565,861 |
The cost of inventories recognized as cost of goods sold for the three months ended March 31, 2026 and 2025 were $671,293 thousand and $608,113 thousand, respectively. The cost of goods sold included inventory write-downs and scrapping losses for the three months ended March 31, 2026 and 2025 were $3,240 thousand and $891 thousand, respectively..
12. Subsidiaries
a. Subsidiaries included in the consolidated financial statements
The entities included in the consolidated financial statements are as follows, and there is no subsidiary excluding from the consolidated financial statements:
| Investor | Investee | Nature of Activities | Proportion of Ownership | Remark | ||
| March 31, 2026 | December 31, 2025 | March 31, 2025 | ||||
| The Company | Data Image (MAURITIUS) Corporation | Investment | 100.00% | 100.00% | 100.00% | |
| DIVA Laboratories, Ltd. | Medical equipment manufacturing and sales | 36.26% | 36.26% | 36.26% | 1 and 2 | |
| DIVA Laboratories, Ltd. | DIVA Laboratories U.S., LLC. | Sales of monitor | 100.00% | 100.00% | 100.00% | |
| DIVA Laboratories GmbH | Sales of monitor | 100.00% | 100.00% | 100.00% | ||
| Diva Capital Inc. | Reinvestment | 100.00% | 100.00% | 100.00% | ||
| Diva Capital Inc. | Diva Holding Inc. | Reinvestment | 100.00% | 100.00% | 100.00% | |
| Diva Holding Inc. | Suzhou Diva Lab. Inc. | Wholesale and import and export of medical equipment | 100.00% | 100.00% | 100.00% | |
| Data Image (MAURITIUS) Corporation | Data Image (Suzhou) Corporation | Manufacturing, processing, and sale of LCD touch modules and LCD modules | 100.00% | 100.00% | 100.00% | |
1) The Company held 36.26% of the equity in DIVA Laboratories, Ltd, and controls more than half of the directors of DIVA Laboratories, Ltd. It is considered that the Company has the substantial ability to lead its relevant activities; therefore, it is included as a subsidiary.
2) A subsidiary with significant non-controlling interests.
b. Details of subsidiaries that have material non-controlling interests
| Name of Subsidiary | Principal Place of Business | Proportion of Ownership and Voting Rights Held by Non-controlling Interests | ||
| March 31, 2026 | December 31, 2025 | March 31, 2025 | ||
| DIVA Laboratories, Ltd. | New Taipei City | 63.74% | 63.74% | 63.74% |
Profit (Loss) Allocated to Non-controlling Interests
| For the Three Months Ended March 31 | Non-controlling Interests | ||||
| 2026 | 2025 | March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| DIVA Laboratories, Ltd. | $ 12,876 | $ 12,944 | $ 733,353 | $ 795,611 | $ 763,007 |
The summarized financial information of the Group's subsidiary below represents amounts before intragroup eliminations.
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| Current assets | $ 1,117,166 | $ 1,084,365 | $ 1,061,989 |
| Non-current assets | 675,230 | 683,963 | 703,980 |
| Current liabilities | (446,329) | (323,446) | (366,472) |
| Non-current liabilities | (30,703) | (31,843) | (37,610) |
| Equity | $ 1,315,364 | $ 1,413,039 | $ 1,361,887 |
| Equity attributable to: | |||
| Owners of the Company | $ 582,011 | $ 617,428 | $ 598,880 |
| Non-controlling interests | 733,353 | 795,611 | 763,007 |
| $ 1,315,364 | $ 1,413,039 | $ 1,361,887 |
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Revenue | $ 222,900 | $ 207,110 |
| Net income | $ 20,201 | $ 20,307 |
| Other comprehensive income | (539) | 1,217 |
| Total comprehensive income | $ 19,662 | $ 21,524 |
| Net income attributable to: | ||
| Owners of the Company | $ 7,325 | $ 7,363 |
| Non-controlling interests | 12,876 | 12,944 |
| $ 20,201 | $ 20,307 | |
| Total comprehensive income attributable to: | ||
| Owners of the Company | $ 7,130 | $ 7,805 |
| Non-controlling interests | 12,532 | 13,719 |
| $ 19,662 | $ 21,524 | |
| Cash flow | ||
| Operating activities | $ (16,937) | $ 2,567 |
| Investing activities | (1,250) | 1,128 |
| Financing activities | (822) | (662) |
| Effect of exchange rate changes on cash and cash equivalents | 615 | 407 |
| Net cash inflow | $ (18,394) | $ 3,440 |
^{}[] - 19 -
13. Investment accounted for using the equity method
Investment in associates
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| Associates that are not individually material | |||
| DMC Components International, LLC | $ 7,516 | $ 7,602 | $ 8,245 |
| The Linden Group Corp. | 2,050 | 2,028 | (694) |
| Add: Credit balance of investment accounted for using the equity method transferred to other non-current liabilities | - | - | 694 |
| 2,050 | 2,028 | - | |
| $ 9,566 | $ 9,630 | $ 8,245 |
Associates that are not individually material
| Name of Associate | Nature of Activities | Principal Place of Business | Proportion of Ownership and Voting Rights | ||
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |||
| DMC Components International, LLC | Sales agency | Orlando, USA | 30% | 30% | 30% |
| The Linden Group Corp. | Sales of monitor | USA | 19% | 19% | 19% |
Although DIVA Laboratories, Ltd. holds less than 20% of the shares in The Linden Group Corp., it is assessed that the Group has significant influence over the company.
The Linden Group Corp., accounted for using the equity method by DIVA Laboratories, Ltd. As of March 31, 2026, the cumulative impairment loss was $25,787 thousand.
For the three months ended March 31, 2026 and 2025, investments were accounted for using the equity method and the share of profit or loss and other comprehensive income of those investments were calculated based on financial statements which have not been reviewed.
14. Property, plant and equipment
| Land | Buildings | Machinery | Other Equipment | Total | |
| Cost | |||||
| Balance on January 1, 2026 | $ 280,641 | $ 655,252 | $ 396,327 | $ 106,373 | $ 1,438,593 |
| Additions | - | - | 1,637 | 7,564 | 9,201 |
| Disposals/derecognitions | - | - | (268) | (2,568) | (2,836) |
| Reclassification | - | - | 664 | 1,475 | 2,139 |
| Effects of foreign currency exchange differences | - | 13,780 | 9,711 | 1,880 | 25,371 |
| Balance on March 31, 2026 | $ 280,641 | $ 669,032 | $ 408,071 | $ 114,724 | $ 1,472,468 |
| Accumulated depreciation | |||||
| Balance on January 1, 2026 | $ - | $ 294,142 | $ 309,923 | $ 64,949 | $ 669,014 |
| Depreciation expenses | - | 5,394 | 4,279 | 3,910 | 13,583 |
| Disposals/derecognitions | - | - | (268) | (2,518) | (2,786) |
| Effects of foreign currency exchange differences | - | 7,238 | 7,677 | 1,303 | 16,218 |
| Balance on March 31, 2026 | $ - | $ 306,774 | $ 321,611 | $ 67,644 | $ 696,029 |
| Carrying amount on March 31, 2026 | $ 280,641 | $ 362,258 | $ 86,460 | $ 47,080 | $ 776,439 |
(Continued)
^{}[] - 20 -
| Land | Buildings | Machinery | Other Equipment | Total | |
|---|---|---|---|---|---|
| Carrying amount on December 31, 2025 and January 1, 2026 | $ 280,641 | $ 361,110 | $ 86,404 | $ 41,424 | $ 769,579 |
| Cost | |||||
| Balance on January 1, 2025 | $ 280,641 | $ 654,880 | $ 375,661 | $ 121,030 | $ 1,432,212 |
| Additions | - | - | 3,718 | 2,571 | 6,289 |
| Disposals/derecognitions | - | - | (38) | (17,403) | (17,441) |
| Effects of foreign currency exchange differences | - | 8,758 | 5,982 | 1,094 | 15,834 |
| Balance on March 31, 2025 | $ 280,641 | $ 663,638 | $ 385,323 | $ 107,292 | $ 1,436,894 |
| Accumulated depreciation | |||||
| Balance on January 1, 2025 | $ - | $ 272,473 | $ 298,731 | $ 84,839 | $ 656,043 |
| Depreciation expenses | - | 5,373 | 3,908 | 3,736 | 13,017 |
| Disposals/derecognitions | - | - | (34) | (17,342) | (17,376) |
| Effects of foreign currency exchange differences | - | 4,345 | 4,718 | 745 | 9,808 |
| Balance on March 31, 2025 | $ - | $ 282,191 | $ 307,323 | $ 71,978 | $ 661,492 |
| Carrying amount on March 31, 2025 | $ 280,641 | $ 381,447 | $ 78,000 | $ 35,314 | $ 775,402 |
The above items of property, plant and equipment leased under operating leases are depreciated on a straight-line basis over their estimated useful lives as follows:
Buildings 30-35 years
Machinery 2-10 years
Other equipment 2-10 years
15. Lease arrangements
a. Right-of-use assets
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
|---|---|---|---|
| Carrying amounts | |||
| Land | $ 9,272 | $ 9,081 | $ 9,504 |
| Buildings | 35,560 | 38,672 | 35,798 |
| Transportation equipment | 1,833 | 2,060 | 2,896 |
| Office equipment | 1,785 | 1,971 | 469 |
| $ 48,450 | $ 51,784 | $ 48,667 |
For the Three Months Ended March 31
| 2026 | 2025 | |
|---|---|---|
| Additions to right-of-use assets | $ - | $ 477 |
| Depreciation charge for right-of-use assets | ||
| Land | $ 84 | $ 84 |
| Buildings | 3,112 | 2,768 |
| Transportation equipment | 227 | 625 |
| Office equipment | 186 | 29 |
| $ 3,609 | $ 3,506 |
Except for the aforementioned addition and recognized depreciation, there was no material sublease agreement or impairment on the Group's right-of-use assets for the three months ended March 31, 2026 and 2025.
b. Lease liabilities
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| Carrying amounts | |||
| Current | $ 13,296 | $ 13,845 | $ 10,812 |
| Non-current | $ 26,966 | $ 29,689 | $ 29,215 |
The range of discount rates for lease liabilities was as follows:
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| Buildings | 2.023%~2.600% | 2.023%~2.600% | 1.350%~2.500% |
| Transportation equipment | 2.150%~2.600% | 2.150%~2.600% | 1.300%~2.150% |
| Office equipment | 2.148%~2.600% | 2.148%~2.600% | 2.148% |
c. Other lease information
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Expenses relating to short-term leases | $ 640 | $ 516 |
| Expenses relating to low-value asset leases | $ 300 | $ 304 |
| Expenses relating to variable lease payments not included in the measurement of lease liabilities | $ 96 | $ 45 |
| Total cash outflow for leases | $ (4,571) | $ (4,477) |
The Group's leases of certain qualify as short-term leases and leases of certain qualify as low-value asset leases. The Group has elected to apply the recognition exemption and thus, did not recognize right-of-use assets and lease liabilities for these leases.
- Goodwill
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Balance on January 1 and March 31 | $ 164,826 | $ 164,826 |
The Group recorded a goodwill of $164,826 thousand generated from the acquisition of DIVA Laboratories, Ltd. on October 27, 2021.
17. Intangible assets
| Patents | Computer Software | Total | |
|---|---|---|---|
| Cost | |||
| Balance on January 1, 2026 | $ 104,636 | $ 46,552 | $ 151,188 |
| Effects of foreign currency exchange differences | - | 289 | 289 |
| Balance on March 31, 2026 | $ 104,636 | $ 46,841 | $ 151,477 |
| Accumulated amortization | |||
| Balance on January 1, 2026 | $ 72,663 | $ 39,828 | $ 112,491 |
| Amortization expenses | 4,360 | 681 | 5,041 |
| Effects of foreign currency exchange differences | - | 176 | 176 |
| Balance on March 31, 2026 | $ 77,023 | $ 40,685 | $ 117,708 |
| Carrying amount on March 31, 2026 | $ 27,613 | $ 6,156 | $ 33,769 |
| Carrying amount on December 31, 2025 and January 1, 2026 | $ 31,973 | $ 6,724 | $ 38,697 |
| Cost | |||
| Balance on January 1, 2025 | $ 104,636 | $ 44,804 | $ 149,440 |
| Disposals/derecognitions | - | (627) | (627) |
| Effects of foreign currency exchange differences | - | 138 | 138 |
| Balance on March 31, 2025 | $ 104,636 | $ 44,315 | $ 148,951 |
| Accumulated amortization and impairment | |||
| Balance on January 1, 2025 | $ 55,224 | $ 38,146 | $ 93,370 |
| Amortization expenses | 4,360 | 706 | 5,066 |
| Disposals/derecognitions | - | (627) | (627) |
| Effects of foreign currency exchange differences | - | 89 | 89 |
| Balance on March 31, 2025 | $ 59,584 | $ 38,314 | $ 97,898 |
| Carrying amount on March 31, 2025 | $ 45,052 | $ 6,001 | $ 51,053 |
Intangible assets are amortized on a straight-line basis over their estimated useful lives as follows:
Patents
5-10 years
Computer software
3-5 years
An analysis of amortization expenses by functions:
| For the Three Months Ended March 31 | ||
|---|---|---|
| 2026 | 2025 | |
| Manufacturing expenses | $ 3,483 | $ 3,483 |
| Selling and marketing expenses | 174 | 174 |
| General and administrative expenses | 523 | 587 |
| Research and development expenses | 861 | 822 |
| $ 5,041 | $ 5,066 | |
^{}[] - 23 -
18. Other assets
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
|---|---|---|---|
| Current | |||
| Prepayments | $ 45,991 | $ 55,403 | $ 27,474 |
| Others | 8,851 | 7,006 | 4,017 |
| $ 54,842 | $ 62,409 | $ 31,491 | |
| Non-current | |||
| Prepayment for equipment | $ 27,362 | $ 27,903 | $ 8,968 |
| Refundable deposits | 3,524 | 3,432 | 9,425 |
| Others | 3,467 | 3,517 | 5,490 |
| $ 34,353 | $ 34,852 | $ 23,883 |
Other non-current assets pledged as collateral for bank borrowings are set out in Note 31.
19. Borrowings
Short-term borrowings
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
|---|---|---|---|
| Credit borrowings | $ 37,059 | $ 35,962 | $ 45,787 |
| The range of interest rate was as follows: | |||
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| Credit borrowings | 2.5%~3.0% | 2.5%~3.0% | 3.1%~3.2% |
20. Accounts payable
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
|---|---|---|---|
| Accounts payable | |||
| Operating | $ 490,457 | $ 519,355 | $ 399,568 |
21. Other payables
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
|---|---|---|---|
| Payables for dividends | $ 206,617 | $ - | $ 215,617 |
| Payables for salaries or bonuses | 60,696 | 94,437 | 58,845 |
| Remunerations of employee | 34,925 | 28,730 | 38,480 |
| Payables for processing fees | 14,635 | 14,729 | 15,526 |
| Payables for annual leave | 12,777 | 14,408 | 11,710 |
| Payables for professional service fees | 8,805 | 8,759 | 10,823 |
| Remunerations of directors | 2,255 | 2,803 | 2,473 |
| Others | 74,305 | 61,935 | 55,806 |
| $ 415,015 | $ 225,801 | $ 409,280 |
^{}[] - 24 -
22. Retirement benefit plans
For the three months ended March 31, 2026 and 2025, the pension expenses of defined benefit plans decreased by $13 thousand and $9 thousand, respectively. These amounts were calculated based on the pension cost rate determined by the actuarial calculation on December 31, 2025 and 2024, respectively.
23. Equity
a. Share capital
Ordinary shares
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| Authorized shares (in thousands) | 200,000 | 200,000 | 200,000 |
| Authorized capital | $ 2,000,000 | $ 2,000,000 | $ 2,000,000 |
| Issued and paid shares (in thousands) | 75,100 | 75,100 | 78,100 |
| Issued capital | $ 750,996 | $ 750,996 | $ 780,996 |
The share issued had a par value of $10 and the right of voting and receiving dividends.
b. Capital surplus
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| May be used to offset a deficit, distributed as cash dividends, or transferred to share capital (Note) | |||
| Issuance of ordinary shares | $ 462,063 | $ 462,063 | $ 480,521 |
| May only be used to offset a deficit | |||
| Exercise of disgorgement | $ 6 | $ 6 | $ 6 |
Note: Such capital surplus may be used to offset a deficit; in addition, when the Company has no deficit, such capital surplus may be distributed as cash dividends or transferred to share capital (limited to a certain percentage of the Company's capital surplus and to once a year).
c. Retained earnings and dividend policy
According to the Company's Articles of Incorporation, the board of directors is authorized to adopt a special resolution to distribute dividends and bonuses in cash and a report of such distribution should be submitted in the shareholders' meeting
Under the dividends policy as set forth in the Articles of Incorporation, where the Company made a profit in a fiscal year, the profit shall be first utilized for paying taxes, offsetting losses of previous years, setting aside as legal reserve 10% of the remaining profit, until the accumulated legal capital reserve equals the Company's paid-in share capital, setting aside or reversing a special reserve in accordance with the laws and regulations, and then any remaining profit together with any undistributed retained earnings shall be used by the Company's board of directors as the basis for proposing a distribution plan, which should be resolved in the shareholders' meeting for the distribution of dividends and bonuses to shareholders. For the policies on the distribution of compensation of employees and remuneration of directors and supervisors after the amendment, refer to compensation of employees and remuneration of directors and supervisors in Note 25(7).
The Company's dividend policy complies with the current and future development plans, taking investment environments, capital requirements, and domestic or foreign competition status into account, and considers shareholders' interest and other factors. The Company made a profit in a fiscal year, and until the distributable earnings equal the Company's paid-in share capital 2%, dividends may be distributed in the form of both cash dividends and share dividends. However, cash dividends are limited to 10% of the total dividends distributed.
An appropriation of earnings to a legal reserve shall be made until the legal reserve equals the Company's paid-in capital. The legal reserve may be used to offset deficits. If the Company has no deficit and the legal reserve has exceeded 25% of the Company's paid-in capital, the excess may be transferred to capital or distributed in cash.
The appropriations of earnings for 2025 and 2024 are as follows:
| 2025 (Note 1) | 2024 (Note 2) | |
| Legal reserve | $ 10,096 | $ 21,973 |
| Reversal of special reserve | $ (2,744) | $ (18,576) |
| Cash dividends | $ 225,299 | $ 234,299 |
| Cash dividends per share (NT$) | $ 3 | $ 3 |
The above 2025 and 2024 appropriations for cash dividends had been resolved by the Company's board of directors on March 2, 2026 and March 4, 2025, respectively; the other proposed appropriations for 2024 had been resolved by the shareholders in their meeting on May 23, 2025. The other proposed appropriations for 2025 will be resolved by the shareholders in their meeting to be held on May 20, 2026.
Note 1: The calculation is based on the 78,100 thousand shares outstanding as of January 1, 2025, net of 3,000 thousand treasury shares approved for cancellation by the board of directors on July 29, 2025, and October 28, 2025, respectively.
Note 2: The calculation is based on the 78,100 thousand shares outstanding as of January 1, 2024.
d. Special reserve
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Balance on January 1 and March 31 | $ 8,278 | $ 26,854 |
When distributing earnings, additional special reserve should be appropriated for the amount equal to the difference between net debit balance reserves and the special reserve appropriated at the end of the reporting period. Any special reserve appropriated may be reversed to the extent that the net debit balance reverses and is thereafter distributed.
e. Other equity items
1) Exchange differences on the translation of the financial statements of foreign operations
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Balance on January 1 | $ (5,995) | $ (8,551) |
| Recognized for the period | ||
| Exchange differences on the translation of the financial statements of foreign operations | 16,948 | 10,085 |
| Share from associates accounted for using the equity method | 161 | 121 |
| Balance on March 31 | $ 11,114 | $ 1,655 |
2) Unrealized valuation gain(loss) on financial assets at FVTOCI
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Balance on January 1 | $ 461 | $ 273 |
| Recognized for the period | ||
| Unrealized gain (loss) | ||
| Equity instruments | (455) | 249 |
| Balance on March 31 | $ 6 | $ 522 |
f. Non-controlling interests
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Balance on January 1 | $ 795,611 | $ 824,078 |
| Net income | 12,876 | 12,944 |
| Other comprehensive income | ||
| Exchange differences on translation of the financial statements of foreign operations | 417 | 322 |
| Unrealized gain (loss) on financial assets at FVTOCI | (801) | 438 |
| Share in other comprehensive income of associates accounted for using the equity method | 40 | 15 |
| Cash dividends distributed by subsidiaries | (74,790) | (74,790) |
| Balance on March 31 | $ 733,353 | $ 763,007 |
- Revenue
a. Breakdown of revenue from contracts with customers
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| LCD touch module | $ 590,645 | $ 539,409 |
| LCD module | 55,738 | 62,993 |
| Medical and industrial displays | 176,145 | 139,155 |
| Others | 47,132 | 74,827 |
| $ 869,660 | $ 816,384 | |
b. Contract balance
| March 31, 2026 | December 31, 2025 | March 31, 2025 | January 1, 2025 | |
|---|---|---|---|---|
| Accounts receivable (Note 10) | $ 701,802 | $ 713,808 | $ 661,947 | $ 683,893 |
| Accounts receivable from related parties | $ 22,181 | $ 27,088 | $ 26,569 | $ 26,329 |
| Contract liabilities - Current | $ 45,857 | $ 45,740 | $ 98,714 | $ 100,551 |
The changes in the balance of contract assets and contract liabilities primarily result from the timing difference between the Group’s satisfaction of performance obligations and the respective customer’s payment.
Revenue in the current year that was recognized from the performance obligations satisfied with the contract liability Balance on the beginning of the year was summarized as follows:
| For the Three Months Ended March 31 | ||
|---|---|---|
| 2026 | 2025 | |
| From contract liabilities at the start of the year | $ 1,895 | $ 4,045 |
- Net income
a. Interest income
| For the Three Months Ended March 31 | ||
|---|---|---|
| 2026 | 2025 | |
| Bank deposits | $ 1,755 | $ 2,067 |
b. Other income
| For the Three Months Ended March 31 | ||
|---|---|---|
| 2026 | 2025 | |
| Others (Note 30) | $ 340 | $ 2,944 |
c. Other gains and losses
| For the Three Months Ended March 31 | ||
|---|---|---|
| 2026 | 2025 | |
| Valuation gain (loss) on financial assets and liabilities | ||
| Financial assets mandatorily measured at FVTPL | $ (2,435) | $ 374 |
| Financial liabilities held for trading | (7,372) | (9,362) |
| Net foreign exchange gains | 8,692 | 6,915 |
| Loss on disposal of property, plant and equipment | (50) | (65) |
| Other gains | 2,192 | 571 |
| Other losses | (99) | - |
| $ 928 | $ (1,567) | |
d. Finance cost
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Interest on bank loans | $ 414 | $ 367 |
| Interest on lease liabilities | 263 | 249 |
| $ 677 | $ 616 | |
e. Depreciation and amortization
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Property, plant and equipment | $ 13,583 | $ 13,017 |
| Right-of-use assets | 3,609 | 3,506 |
| Intangible assets | 5,041 | 5,066 |
| $ 22,233 | $ 21,589 | |
| An analysis of depreciation by function | ||
| Operating costs | $ 9,785 | $ 9,229 |
| Operating expenses | 7,407 | 7,294 |
| $ 17,192 | $ 16,523 | |
| An analysis of amortization by function | ||
| Operating costs | $ 3,483 | $ 3,483 |
| Operating expenses | 1,558 | 1,583 |
| $ 5,041 | $ 5,066 | |
f. Employee benefits expense
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Short-term benefits | $ 154,158 | $ 143,713 |
| Post-employment benefits | ||
| Defined contribution plan | 10,013 | 9,157 |
| Defined benefit plan (Note 22) | (13) | (9) |
| 10,000 | 9,148 | |
| Other employee benefits | 15,962 | 11,855 |
| $ 180,120 | $ 164,716 | |
| An analysis of employee benefits expense by function | ||
| Operating cost | $ 89,041 | $ 76,148 |
| Operating expenses | 91,079 | 88,568 |
| $ 180,120 | $ 164,716 | |
g. Compensation of employees and remuneration of directors
According to the Articles of Incorporation, where the Company made a profit in a fiscal year, the Company accrues compensation of employees at rates of no less than 5% and no higher than 20% and accrues remuneration of directors at rates of no higher than 1%. In accordance with the amendments to the Securities and Exchange Act in August 2024, the shareholders of the Company expect to resolve the amendments to the Company's Articles at their 2025 regular meeting. The amendments explicitly stipulate the allocation of non-executive employees at rates of no less than 10% of the total compensation
of employees mentioned above. The compensation of employees (including non-executive employees) and the remuneration of directors for the three months ended March 31, 2026 and 2025 are as follows:
Accrual rate
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Compensation of employees | 8.00% | 8.00% |
| Remuneration of directors | 0.75% | 0.75% |
Amount
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Compensation of employees | $ 4,127 | $ 4,580 |
| Remuneration of directors | 387 | 429 |
The appropriations of employees' compensation and remuneration of directors for 2025 and 2024 that were resolved by the board of directors on March 2, 2026 and March 4, 2025, respectively, are as shown below:
Amount
| 2025 | 2023 | |
| Compensation of employees | $ 20,553 | $ 22,810 |
| Remuneration of directors | 1,927 | 2,138 |
If there is a change in the amounts after the annual consolidated financial statements are authorized for issue, the differences are recorded as a change in the accounting estimate.
There is no difference between the actual amounts of compensation of employees and remuneration of directors paid and the amounts recognized in the consolidated financial statements for the years ended December 31, 2025 and 2024.
Information on the compensation of employees and remuneration of directors resolved by the Company's board of directors is available at the Market Observation Post System website of the Taiwan Stock Exchange.
26. Income tax
a. Major components of income tax expenses recognized in profit or loss
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Current tax | ||
| In respect of the current period | $ 13,365 | $ 16,110 |
| Adjustments for prior year | (9,849) | - |
| Other | 584 | 822 |
| 4,100 | 16,932 | |
| Deferred tax | ||
| In respect of the current period | (1,027) | (797) |
| Income tax expenses recognized in profit or loss | $ 3,073 | $ 16,135 |
b. Income tax assessments
The income tax for the Company and DIVA Laboratories, Ltd returns through 2024, have been assessed by the tax authorities.
27. Earnings per share
Unit: NTS per share
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Basic earnings per share | $ 0.60 | $ 0.56 |
| Diluted earnings per share | $ 0.60 | $ 0.56 |
The earnings and weighted average number of ordinary shares outstanding used in the computation of earnings per share were as follows:
Net Income
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Earnings used in the computation of basic and diluted earnings per share | $ 45,035 | $ 44,023 |
Weighted average number of ordinary shares outstanding (in thousands of shares)
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Weighted average number of ordinary shares used in the computation of basic earnings per share | 75,100 | 78,100 |
| Effect of potentially dilutive ordinary shares: Compensation of employees | 439 | 427 |
| Weighted average number of ordinary shares used in the computation of diluted earnings per share | 75,539 | 78,527 |
The Group may settle the compensation of employees in cash or shares; therefore, the Group assumes that the entire amount of the compensation will be settled in shares, and the resulting potential shares are included in the weighted average number of shares outstanding used in the computation of diluted earnings per share, as the effect is dilutive. Such dilutive effect of the potential shares is included in the computation of diluted earnings per share until the number of shares to be distributed to employees is resolved in the following year.
28. Capital management
The Group manages its capital to ensure the Group will be able to continue as going concerns with a capital structure that is most suitable for the Group's current operation and development and make good use of various equity and debt instruments to provide the Group with capital required for operating plans, while maximizing the return to stakeholders.
The capital structure of the Group consists of net debt and equity attributable to owners of the Company.
The Group is not subject to any externally imposed capital requirements.
29. Financial instruments
a. Fair value of financial instruments not measured at fair value
For financial instruments not measured at fair value, that maturities are near or that future receipt or payment amounts approximate their carrying amounts, their fair values are estimated based on their carrying amounts as of the consolidated balance sheet date.
b. Fair value of financial instruments measured at fair value on a recurring basis
1) Fair value hierarchy
March 31, 2026
| Level 1 | Level 2 | Level 3 | Total | |
| Financial assets at FVTPL | ||||
| Domestic unlisted shares | $ - | $ - | $ - | $ - |
| Derivatives | $ - | $ 41 | $ - | $ 41 |
| $ - | $ 41 | $ - | $ 41 | |
| Financial assets at FVTOCI | ||||
| Investment in equity instruments | ||||
| Domestic unlisted shares | $ - | $ - | $ 4,294 | $ 4,294 |
| Financial liabilities at FVTPL | ||||
| Derivatives | $ - | $ 3,026 | $ - | $ 3,026 |
| December 31, 2025 | ||||
| Level 1 | Level 2 | Level 3 | Total | |
| Financial assets at FVTPL | ||||
| Domestic unlisted shares | $ - | $ - | $ - | $ - |
| Derivatives | $ - | $ 140 | $ - | $ 140 |
| $ - | $ 140 | $ - | $ 140 | |
| Financial assets at FVTOCI | ||||
| Investment in equity instruments | ||||
| Domestic unlisted shares | $ - | $ - | $ 5,550 | $ 5,550 |
| Financial liabilities at FVTPL | ||||
| Derivatives | $ - | $ 2,077 | $ - | $ 2,077 |
| March 31, 2025 | ||||
| Level 1 | Level 2 | Level 3 | Total | |
| Financial assets at FVTPL | ||||
| Domestic unlisted shares | $ - | $ - | $ - | $ - |
| Financial assets at FVTOCI | ||||
| Investment in equity instruments | ||||
| Domestic unlisted shares | $ - | $ - | $ 5,719 | $ 5,719 |
| Financial liabilities at FVTPL | ||||
| Derivatives | $ - | $ 4,019 | $ - | $ 4,019 |
There were no transfers between Levels 1 and 2 in the current and prior years
- 31 -
2) Reconciliation of Level 3 fair value measurements of financial instruments
For the Three Months Ended March 31, 2026
| Financial assets | Financial Assets at FVTPL | Financial Assets at FVTOCI | Total |
|---|---|---|---|
| Equity instruments | Equity instruments | ||
| Balance on January 1 | $ - | $ 5,550 | $ 5,550 |
| Recognized in other comprehensive income (included in unrealized valuation gain (loss) on financial assets at FVTOCI) | - | (1,256) | (1,256) |
| Balance on March 31 | $ - | $ 4,294 | $ 4,294 |
For the Three Months Ended March 31, 2025
| Financial assets | Financial Assets at FVTPL | Financial Assets at FVTOCI | Total |
|---|---|---|---|
| Equity instruments | Equity instruments | ||
| Balance on January 1 | $ - | $ 5,032 | $ 5,032 |
| Recognized in other comprehensive income (included in unrealized valuation gain (loss) on financial assets at FVTOCI) | - | 687 | 687 |
| Balance on March 31 | $ - | $ 5,719 | $ 5,719 |
3) Valuation techniques and inputs applied for Level 2 fair value measurement
| Financial Instrument | Valuation Technique and Inputs |
|---|---|
| Derivatives - foreign exchange forward contracts and foreign exchange swap contracts | Discounted cash flow: Future cash flows are estimated based on observable forward exchange rates at the end of the period and contract forward rates, discounted at a rate that reflects the credit risk of various counterparties. |
4) Valuation techniques and inputs applied for Level 3 fair value measurement
The domestic unlisted shares held by the Group and there was no market value for reference; therefore, the valuation method was adopted.
c. Categories of financial instruments
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
|---|---|---|---|
| Financial assets | |||
| FVTPL | |||
| Mandatorily measured as at FVTPL | $ 41 | $ 140 | $ - |
| Financial assets at amortized cost | |||
| Cash and cash equivalents | 992,295 | 1,024,524 | 1,365,282 |
| Accounts receivable | 701,802 | 713,808 | 661,947 |
| Accounts receivable from related parties | 22,181 | 27,088 | 26,569 |
| (Continued) |
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| Other receivables | $ 4,467 | $ 9,131 | $ 2,235 |
| Other receivables from related parties | 13,449 | 10,544 | 11,385 |
| Restricted assets (accounted for as other current assets) | 2,000 | 2,000 | - |
| Financial assets at amortized cost - non-current | 1,054 | 1,054 | - |
| Refundable deposits | 3,524 | 3,432 | 9,425 |
| Financial assets FVTOCI | |||
| Equity instruments | 4,294 | 5,550 | 5,719 |
| Financial liabilities | |||
| FVTPL | |||
| Held for trading | 3,026 | 2,077 | 4,019 |
| Amortized cost | |||
| Short-term borrowings | 37,059 | 35,962 | 45,787 |
| Accounts payable | 490,457 | 519,355 | 399,568 |
| Accounts payable from related parties | 13,928 | 8,835 | 5,844 |
| Other payables | 415,015 | 225,801 | 409,280 |
| Other payables from related parties | 196,213 | 96,662 | 132,967 |
| Guarantee deposits received | 93 | 90 | 489 |
d. Financial risk management objectives and policies
The financial risks related to the operating activities of the Group are market risk, credit risk and liquidity risk. Except for market risk, which is affected by external factors and is unpredictable, the remaining two risks can be generally controlled or eliminated through internal control or operating procedures. Therefore, in response to changes in market risks, the Group uses appropriate financial instrument operations to reduce the adverse effects that market risks may have on the Group's financial position and financial performance.
1) Market risk
The Group's activities exposed it primarily to the market risks include foreign currency exchange rates and interest rates.
a) Foreign currency risk
The Group have foreign currency denominated sales and purchases, which expose to foreign currency risk. Exchange rate exposures are managed within approved policy parameters utilizing foreign exchange forward contracts.
The carrying amounts of the Group's foreign currency denominated monetary assets and monetary liabilities (including those eliminated on consolidation) at the end of the period are set out in Note 32.
Sensitivity analysis
The Group is mainly exposed to the U.S. dollars.
The following table details the Group's sensitivity to a 1% increase and decrease in each functional currency against the relevant foreign currencies. The sensitivity analysis included only outstanding foreign currency denominated monetary items and foreign exchange forward contracts designated as cash flow hedges and adjusts their translation at the end of the period
for a 1% change in foreign currency rates. A positive number below indicates an increase/a decrease in pre-tax profit associated with each functional currency strengthening 1% against the relevant currency. For a 1% weakening of each functional currency against the relevant currency, there would be an equal and opposite impact on pre-tax profit, and the balances below would be negative.
| Impact of U.S. dollars | ||
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Profit and loss | $ (5,006) | $ (4,546) |
b) Interest rate risk
The Group's risk of changes in interest rates mainly comes from short-term borrowings and long-term borrowings with fixed and floating interest rates. Changes in market interest rates will change the effective interest rate of borrowings, resulting in the risk of changes in the future fair value and cash flow.
The carrying amounts of the Group's financial assets and financial liabilities with exposure to interest rates at the end of the period were as follows:
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
| Fair value interest rate risk | |||
| Financial assets | $ 446,454 | $ 454,654 | $ 634,636 |
| Financial liabilities | 58,792 | 61,515 | 62,921 |
| Cash flow interest rate risk | |||
| Financial assets | 548,514 | 572,460 | 730,654 |
| Financial liabilities | 18,529 | 17,981 | 22,893 |
Sensitivity analysis
The sensitivity analysis below was determined based on the Group's exposure to interest rates for non-derivative instruments at the end of the reporting period. For floating rate liabilities, the analysis was prepared assuming the amount of each liability outstanding at the end of the period was outstanding for the whole year.
If interest rates had been 1% basis points higher/lower and all other variables were held constant, the Group's pre-tax profit for the three months ended March 31, 2026 and 2025 would have decreased/increased by $1,325 thousand and $1,769 thousand, respectively.
2) Credit risk
Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in a financial loss to the group. At the end of the period, the Group's maximum exposure to credit risk, due to the failure of the counterparty to discharge its obligation, could be equal to the carrying amount of the respective recognized financial assets as stated in the consolidated balance sheets.
To mitigate credit risk, the Group's management has assigned a dedicated team to be responsible for credit limit determination, credit approval and other monitoring procedures to ensure that appropriate actions have been taken in the recovery of overdue receivables. In addition, the Group reviews the recoverable amounts of amounts receivable on a case-by-case basis on the balance sheet date to ensure that appropriate impairment losses have been provided for uncollectible amounts
receivable. Accordingly, the Group's management considers that the Group's credit risk has been significantly reduced.
3) Liquidity risk
The Group maintains sufficient cash and cash equivalents to meet the cash requirements for operating activities through accounts and financing management and reduces the impact of cash flow fluctuations. The Group's Finance Department monitors the use of bank financing limits at all times and ensures compliance with the terms of borrowing contracts.
Liquidity and interest rate risk tables for non-derivative financial liabilities
The following table details the Group's remaining contractual maturities for its non-derivative financial liabilities with agreed upon repayment periods. The table has been drawn up based on the undiscounted cash flows of financial liabilities from the earliest date on which the Group can be required to pay. The table includes both interest and principal cash flows. Specifically, bank loans with a repayment on demand clause were included in the earliest time band regardless of the probability of the banks choosing to exercise their rights. The maturity dates for other non-derivative financial liabilities were based on the agreed upon repayment dates
To the extent that interest flows are at floating rates, the undiscounted amount was derived from the interest rate curve at the end of the period.
The current portion of non-interest-bearing financial liabilities is due within one year. These liabilities are not subject to any contractual obligations requiring immediate settlement. The non-current financial liabilities primarily comprise guarantee deposits received from customers, which serve as credit collateral. These deposits do not have specified maturity dates.
March 31, 2026
| Within 1 Year | 1-5 Years | |
|---|---|---|
| Non-derivative financial liabilities | ||
| Lease liabilities | $ 14,139 | $ 27,804 |
| Variable interest rate instruments | 18,667 | - |
| Fixed interest rate instruments | 18,624 | - |
| $ 51,430 | $ 30,707 | |
| December 31, 2025 | ||
| Within 1 Year | 1-5 Years | |
| Non-derivative financial liabilities | ||
| Lease liabilities | $ 14,771 | $ 30,707 |
| Variable interest rate instruments | 18,241 | - |
| Fixed interest rate instruments | 18,177 | - |
| $ 51,189 | $ 30,707 | |
| March 31, 2025 | ||
| Within 1 Year | 1-5 Years | |
| Non-derivative financial liabilities | ||
| Lease liabilities | $ 11,656 | $ 30,468 |
| Variable interest rate instruments | 23,048 | - |
| Fixed interest rate instruments | 23,047 | - |
| $ 57,751 | $ 30,468 |
The amounts included above for variable interest rate instruments for non-derivative financial liabilities are subject to change if changes in variable interest rates differ from those estimates of interest rates determined at the end of the period.
30. Related party transactions
The Company's parent is Qisda Corporation, which held 32.35%, 32.35% and 31.11% of the ordinary shares of the Company at March 31, 2026, December 31 and March 31, 2025, respectively.
Balances and transactions between the Company and its subsidiaries, which are related parties of the Company, have been eliminated on consolidation and are not disclosed in this note. Besides information disclosed elsewhere in the other notes, details of transactions between the Group and other related parties are disclosed as follows.
a. Related parties and their relationship with the Group
| Related Party | Relationship with the Group |
|---|---|
| Qisda Corporation | Parent company |
| Darfon Electronics Corp. | A corporate Director who values the parent company by using the equity method |
| AUO Display Plus Corporation | A subsidiary of AUO Corporation |
| DFI Inc. | Sister company |
| Qisda (Suzhou) Co., Ltd. | Sister company |
| Qisda Optronics (Suzhou) Co., Ltd. | Sister company |
| Qisda Electronics (Suzhou) Co. Ltd. | Sister company |
| Qisda Precision Industry (SuZhou) Co., Ltd. | Sister company |
| Qisda Vietnam Co.,Ltd. | Sister company |
| BenQ Asia Pacific Corp. | Sister company |
| BenQ Material Corp. | Sister company |
| BenQ Healthcare Corporation | Sister company |
| BenQ Medical Technology Corporation | Sister company |
| BenQ Materials (Suzhou) Corp. | Sister company |
| Global Intelligence Network Co., Ltd. | Sister company |
| Simula Technology Inc. | Sister company |
| Metaguru Corporation | Sister company |
| Golden Spirit Co., Ltd. | Sister company |
| Concord Medical Co., Ltd | Sister company |
| Action Star Technology Co., Ltd. | Sister company |
| Norbel Baby Co., Ltd. | Sister company |
| Darly Venture Inc. | Sister company |
| Darly2 Venture, Inc. | Sister company |
| DMC Components International, LLC | Associate |
| The Linden Group Corp. | Associate |
| BenQ (Suzhou) Foundation | Substantial related party |
| Aplex Technology Inc. | Substantial related party |
| Gene Chen | Substantial related party |
b. Operating revenue
| Related Party Category | For the Three Months Ended March 31 | |
|---|---|---|
| 2026 | 2025 | |
| Parent company | $ 272 | $ 451 |
| Sister company | 2,443 | 3,188 |
| Associate | 22,748 | 22,726 |
| Substantial related party | 124 | 496 |
| $ 25,587 | $ 26,861 | |
As most of the Group's transactions with the abovementioned related parties are customized products with no comparable products, the prices are negotiated by both parties.
c. Purchases
| Related Party Category | For the Three Months Ended March 31 | |
|---|---|---|
| 2026 | 2025 | |
| Parent company | $ 207 | $ - |
| A corporate Director who values the parent company by using the equity method | 6 | - |
| A subsidiary of AUO Corporation | 15,114 | 6,924 |
| Sister company | 97 | 1,249 |
| $ 15,424 | $ 8,173 | |
As most of the transactions with the abovementioned related parties are raw materials required by customized products with no comparable products, the prices are negotiated by both parties.
d Receivables from related parties
| Item | Related Party Category/Name | March 31, 2026 | December 31, 2025 | March 31, 2025 |
|---|---|---|---|---|
| Accounts receivables | Parent company | $ 260 | $ 245 | $ 464 |
| Sister company | 2,899 | 9,034 | 2,879 | |
| Associate | 18,890 | 17,519 | 22,991 | |
| Substantial related party | 132 | 290 | 235 | |
| $ 22,181 | $ 27,088 | $ 26,569 | ||
| Other receivables | Sister company | $ 13,344 | $ 10,441 | $ 11,281 |
| Associate | 105 | 103 | 104 | |
| $ 13,449 | $ 10,544 | $ 11,385 |
The outstanding accounts receivable from related parties are unsecured. For the three months ended March 31, 2026 and 2025, no impairment losses were recognized for trade receivables from related parties.
e. Payables to related parties
| Item | Related Party Category | March 31, 2026 | December 31, 2025 | March 31, 2025 |
|---|---|---|---|---|
| Accounts payable | Parent company | $ 133 | $ 89 | $ - |
| A corporate Director who values the parent company by using the equity method | 6 | 1 | - | |
| A subsidiary of AUO Corporation | 13,557 | 8,516 | 4,557 | |
| Sister company | 232 | 229 | 1,287 | |
| $ 13,928 | $ 8,835 | $ 5,844 | ||
| Other payables | Parent company (Note 1) | $ 156,302 | $ 81,463 | $ 103,711 |
| Sister company (Note 1) | 30,788 | 9,048 | 24,358 | |
| Associate | 9,123 | 6,151 | 4,898 | |
| $ 196,213 | $ 96,662 | $ 132,967 |
The outstanding accounts payable to related parties are unsecured.
Note 1: As of March 31, 2026 and 2025, other payables included dividend payable both amounting to $93,472 thousand.
f. Contract liabilities
| Related Party Category | March 31, 2026 | December 31, 2025 | March 31, 2025 |
|---|---|---|---|
| Associate | $ 95 | $ 79 | $ - |
g. Prepayments (accounted for as other current and non-current assets)
| Related Party Category | March 31, 2026 | December 31, 2025 | March 31, 2025 |
|---|---|---|---|
| Sister company | $ 1,417 | $ 1,568 | $ 178 |
h. Lease agreement
| Item | Related Party Category | March 31, 2026 | December 31, 2025 | March 31, 2025 |
|---|---|---|---|---|
| Lease liabilities | Parent company | $ 9,475 | $ 10,195 | $ 150 |
| Item | Related Party Category | For the Three Months Ended March 31 | |
|---|---|---|---|
| 2026 | 2025 | ||
| Interest expenses (accounted for as finance cost) | Parent company | $ 65 | $ 2 |
The Group rented the Taoyuan Office from the parent company in November 2021 and the Taoyuan Plant from the parent company in May 2020. The lease terms are 3.5 years and 5 years, respectively, and both leases expired in May 2025. The Group renewed the lease agreements for the Taoyuan office and plant in May 2025. The lease term is 4 years. The rental is based on the rental level of similar assets, and it pays a fixed lease payment monthly according to the lease contract.
i. Other related party transactions
| Related Party Category/Name | For the Three Months Ended March 31 | |
| 2026 | 2025 | |
| Operating cost | ||
| Parent company (Note 2) | $ 10,987 | $ 1,859 |
| A subsidiary of AUO Corporation | - | 47 |
| Sister company | 113 | 323 |
| Associate | 64 | 3 |
| $ 11,164 | $ 2,232 | |
| Operating cost - Processing fee | ||
| Parent company | $ 2,860 | $ 8,221 |
| Sister company | 1,578 | 336 |
| $ 4,438 | $ 8,557 | |
| Operating expenses | ||
| Parent company (Note 2) | $ 201 | $ 669 |
| A subsidiary of AUO Corporation | - | 14 |
| Sister company | 392 | 289 |
| Associate | 17 | 1,329 |
| Substantial related party | - | 22 |
| $ 610 | $ 2,323 | |
| Operating expenses - Commission expense | ||
| Associate | $ 6,376 | $ 3,569 |
| Other income | ||
| Associate | $ 113 | $ - |
| Substantial related party | ||
| Gene Chen | - | 2,120 |
| $ 113 | $ 2,120 | |
Note 2: As the parent company provided partial management services to the Group, the management expenses recognized for the three months ended March 31, 2026 and 2025 were $11,188 thousand and $2,528 thousand, respectively.
Commission expenses are calculated based on the rates agreed upon in contracts and are paid only after the Group has received the relevant accounts receivable for sales of goods as an agent.
j. Remuneration of key management personnel
| For the Three Months Ended March 31 | ||
| 2026 | 2025 | |
| Short-term employee benefits | $ 9,967 | $ 10,454 |
| Post-employment benefits | 54 | 54 |
| $ 10,021 | $ 10,508 | |
The remuneration of directors and key executives, as determined by the remuneration committee, is based on the performance of individuals and market trends.
- Pledged assets
The following assets of the Group have been pledged as the collateral for the collection of business taxes after the release of the imported goods by customs:
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
|---|---|---|---|
| Financial assets at amortized cost - non-current | $ 1,054 | $ 1,054 | $ - |
| Restricted assets (accounted for as other current assets) | 2,000 | 2,000 | - |
| Refundable deposits (accounted for as other non-current assets) | 500 | 500 | 1,536 |
| $ 3,554 | $ 3,554 | $ 1,536 |
- Significant assets and liabilities denominated in foreign currencies
The Group’s significant financial assets and liabilities denominated in foreign currencies aggregated by the foreign currencies other than functional currencies of the entities in the Group and the related exchange rates between the foreign currencies and the respective functional currencies were as follows:
March 31, 2026
| Foreign Currency | Exchange Rate | Carrying Amount | ||
|---|---|---|---|---|
| Financial assets | ||||
| Monetary items | ||||
| USD | $ 28,129 | 31.9950 | (USD: NTD) | $ 900,002 |
| USD | 11,845 | 6.9068 | (USD: CNY) | 378,988 |
| Non-monetary items | ||||
| Investment accounted for using the equity method | ||||
| USD | 299 | 31.9950 | (USD: NTD) | 9,566 |
| Financial liabilities | ||||
| Monetary items | ||||
| USD | 21,759 | 31.9950 | (USD: NTD) | 696,194 |
| USD | 2,570 | 6.9068 | (USD: CNY) | 82,215 |
December 31, 2025
| Foreign Currency | Exchange Rate | Carrying Amount | ||
|---|---|---|---|---|
| Financial assets | ||||
| Monetary items | ||||
| USD | $ 27,953 | 31.4300 | (USD: NTD) | $ 878,552 |
| USD | 11,378 | 6.9919 | (USD: CNY) | 357,601 |
| Non-monetary items | ||||
| Investment accounted for using the equity method | ||||
| USD | 306 | 31.4300 | (USD: NTD) | 9,630 |
| Financial liabilities | ||||
| Monetary items | ||||
| USD | 23,177 | 31.4300 | (USD: NTD) | 728,453 |
| USD | 2,550 | 6.9919 | (USD: CNY) | 80,160 |
^{}[] March 31, 2025
| Foreign Currency | Exchange Rate | Carrying Amount | ||
|---|---|---|---|---|
| Financial assets | ||||
| Monetary items | ||||
| USD | $ 25,273 | 33.2050 | (USD: NTD) | $ 839,173 |
| USD | 9,720 | 7.2521 | (USD: CNY) | 322,771 |
| Non-monetary items | ||||
| Investment accounted for using the equity method | ||||
| USD | 227 | 33.2050 | (USD: NTD) | 7,551 |
| Financial liabilities | ||||
| Monetary items | ||||
| USD | 19,242 | 33.2050 | (USD: NTD) | 639,094 |
| USD | 2,055 | 7.2521 | (USD: CNY) | 68,234 |
For the three months ended March 31, 2026 and 2025, realized and unrealized net foreign exchange gains were $8,692 thousand and $6,915 thousand, respectively. It is impractical to disclose net foreign exchange gains (losses) by each significant foreign currency due to the variety of the foreign currency transactions.
33. Separately disclosed items
a. Information on significant transactions:
1) Financing provided to others: None.
2) Endorsements/guarantees provided: None.
3) Significant marketable securities held (excluding investments in subsidiaries, associates and joint ventures): None.
4) Total purchases from or sales to related parties amounting to at least NT$100 million or 20% of the paid-in capital: Table 1.
5) Receivables from related parties amounting to at least NT$100 million or 20% of the paid-in capital: Table 2.
6) Others: Intercompany relationships and significant intercompany transactions: Table 3.
b. Information on investees: Table 4.
c. Information on investments in mainland China:
1) Information on any investee company in mainland China, showing the name, principal business activities, paid-in capital, method of investment, inward and outward remittance of funds, ownership percentage, net income of investees, investment income or loss, carrying amount of the investment at the end of the period, repatriations of investment income, and limit on the amount of investment in the mainland China area: Table 5.
2) Any of the following significant transactions with investee companies in mainland China, either directly or indirectly through a third party, and their prices, payment terms, and unrealized gains or losses: Table 6.
a) The amount and percentage of purchases and the balance and percentage of the related payables at the end of the period
b) The amount and percentage of sales and the balance and percentage of the related receivables at the end of the period
c) The amount of property transactions and the amount of the resultant gains or losses
d) The balance of negotiable instrument endorsements or guarantees or pledges of collateral at the end of the period and the purposes
e) The highest balance, the ending balance, the interest rate range, and total current period interest with respect to the financing of funds
f) Other transactions that have a material effect on the profit or loss for the year or on the financial position, such as the rendering or receipt of services
34. Segment information
The Group’s chief operating decision maker allocates resources and assesses performance based on financial information categorized by product lines. The LCD module segment and the display module segment are identified as separate operating segments by the chief operating decision maker.
a. Segment revenue and results
The following was an analysis of the Group’s revenue and results by reportable segments:
For the Three Months Ended March 31, 2026
| LCD Module Segment | Display Module Segment | Total | |
|---|---|---|---|
| Revenue from external customers | $ 646,760 | $ 222,900 | $ 869,660 |
| Inter-segment income | 2,360 | - | 2,360 |
| Segment revenue | 649,120 | 222,900 | 872,020 |
| Eliminations | (2,360) | - | (2,360) |
| Consolidated revenue | $ 646,760 | $ 222,900 | $ 869,660 |
| Segment income | $ 35,071 | $ 23,937 | $ 59,008 |
| Interest income | 1,755 | ||
| Other income | 340 | ||
| Other gains and losses | 928 | ||
| Finance cost | (677) | ||
| Share of profit or loss of associates | (370) | ||
| Profit before tax | $ 60,984 |
^{}[] For the Three Months Ended March 31, 2025
| LCD Module Segment | Display Module Segment | Total | |
|---|---|---|---|
| Revenue from external customers | $ 609,277 | $ 207,107 | $ 816,384 |
| Inter-segment revenue | 1,876 | 3 | 1,879 |
| Segment revenue | 611,153 | 207,110 | 818,263 |
| Eliminations | (1,876) | (3) | (1,879) |
| Consolidated revenue | $ 609,277 | $ 207,107 | $ 816,384 |
| Segment income | $ 45,607 | $ 26,018 | $ 71,625 |
| Interest income | 2,067 | ||
| Other income | 2,944 | ||
| Other gains and losses | (1,567) | ||
| Finance cost | (616) | ||
| Share of profit or loss of associates | (1,351) | ||
| Profit before tax | $ 73,102 |
Inter-segment revenue was accounted for according to market prices.
Segment profit represents the profit before tax earned by each segment without share of profit of associates, interest income, other income, exchange gains or losses, valuation gains or losses on financial instruments, finance costs and income tax expense. This was the measure reported to the chief operating decision maker for the purpose of resource allocation and assessment of segment performance.
b. Total segment total assets and liabilities
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |
|---|---|---|---|
| Segment assets | |||
| LCD Module Segment | $ 1,896,783 | $ 1,885,073 | $ 2,024,727 |
| Display Module Segment | 1,751,313 | 1,727,215 | 1,725,059 |
| Unallocated assets | 67,901 | 67,322 | 63,535 |
| Consolidated total assets | $ 3,715,997 | $ 3,679,610 | $ 3,813,321 |
| Segment liabilities | |||
| LCD Module Segment | $ 901,328 | $ 720,182 | $ 873,059 |
| Display Module Segment | 374,813 | 295,892 | 294,270 |
| Unallocated liabilities | 97,413 | 95,225 | 111,055 |
| Consolidated total liabilities | $ 1,373,554 | $ 1,111,299 | $ 1,278,384 |
For the purpose of monitoring segment performance and allocating resources between segments:
(1) All assets were allocated to reportable segments other than interests in associates accounted for using the equity method, and current and deferred tax assets. Goodwill was allocated to the reportable segments. Assets used jointly by reportable segments were allocated on the basis of the revenue earned by individual reportable segments; and
(2) All liabilities were allocated to reportable segments other than credit balance of investment accounted for using the equity method, current and deferred tax liabilities. Liabilities for which reportable segments are jointly liable were allocated in proportion to segment assets.
^{}[] Data Image Corporation and Its Subsidiaries
^{}[] Total purchases from or sales to related parties amounting to at least NT$100 million or 20% of the paid-in capital
^{}[] For the Three Months Ended March 31, 2026
^{}[] (In Thousands of New Taiwan Dollars)
Table 1
| Company Name | Related Party | Relationship | Transaction Details | Abnormal Transaction | Notes/Accounts Receivable (Payable) | Note | |||||
| Purchases/ sales | Amount | % of Total (Note 1) | Payment Terms | Unit price | Payment Terms | Ending Balance | % of Total | ||||
| The Company | Data Image (Suzhou) Corporation | Subsidiary | Processing fees | $ (276,607) | (95) | To be determined subject to the capital status | Based on the agreed prices | To be determined subject to the capital status | $ (373,966) | (68) | |
| Data Image (Suzhou) Corporation | The Company | Parent company | Processing income | 276,607 | 97 | To be determined subject to the capital status | Based on the agreed prices | To be determined subject to the capital status | 373,966 | 99 | |
Note 1: The processing fees are calculated as a percentage of the total manufacturing expenses.
Note 2: Transactions between Group have been fully written off when preparing the consolidated financial statements.
- 44 -
^{}[] Data Image Corporation and Its Subsidiaries
^{}[] Receivables from Related Parties Amounting to at least NT$100 million or 20% of the Paid-in Capital
^{}[] March 31, 2026
^{}[] (In Thousands of New Taiwan Dollars, Unless Stated Otherwise)
Table 2
| Company Name | Related Party | Relationship | Ending Balance | Turnover Rate | Overdue | Amount Received in Subsequent Period | Allowance for Impairment Loss | |
| Amount | Actions Taken | |||||||
| Data Image (Suzhou) Corporation | The Company | Parent company | $ 373,966 | 2.68 | $ - | — | $ 185,353 | $ - |
Note: Transactions between Group have been fully written off when preparing the consolidated financial statements.
- 45 -
^{}[] Data Image Corporation and Its Subsidiaries
^{}[] Intercompany relationships and significant Intercompany transactions
^{}[] For the Three Months Ended March 31, 2026
^{}[] (In Thousands of New Taiwan Dollars)
Table 3
| No. | Investee Company | Counterparty | Relationship (Note 1) | Transaction Details | |||
| Financial Statement Accounts | Amount | Payment Terms | % of Total Sales or Assets | ||||
| 0 | The Company | Data Image (Suzhou) Corporation | 1 | Accounts payable from related parties | $ (373,966) | — | 10% |
| Commissioned processing fees | 276,607 | Note 2 | 32% | ||||
| 1 | Data Image (Suzhou) Corporation | The Company | 2 | Processing income | (276,607) | Note 2 | 32% |
| Accounts receivable from related parties | 373,966 | — | 10% | ||||
Note 1: There are two types of relationships with the trader: 1. The Company to a subsidiary; 2. A subsidiary to the Company; 3. A subsidiary to another subsidiary.
Note 2: The Company sells raw materials and semi-finished products to Data Image (Suzhou) Corporation, and then it purchases partial finished products and semi-finished products from the company to sell to customers. As the processing is without imported materials, the related sales revenue is expressed as a net amount.
Note 3: Transactions between Group have been fully written off when preparing the consolidated financial statements.
Note 4: Business relationships and significant transactions that reach at least 1% of the consolidated operating revenue or total assets of the Group shall be disclosed.
- 46 -
Data Image Corporation and Its Subsidiaries
Information on Investees
For the Three Months Ended March 31, 2026
(In Thousands of New Taiwan Dollars, Unless Stated Otherwise)
Table 4
| Investor Company | Investee Company | Location | Main Businesses and Products | Original Investment Amount | As of March 31, 2026 | Net Income (Loss) of the Investee | Share of Profit (Loss) | Note | |||
| March 31, 2026 | December 31, 2025 | Number of shares | Ratio (%) | Carrying amount | |||||||
| The Company | Data Image (MAURITIUS) Corporation | Mauritius | Investment | $ 518,381 | $ 518,381 | 20,215,000 | 100.00 | $ 564,806 | $ (2,811) | $ (2,811) | — |
| DIVA Laboratories, Ltd. | Taiwan | Medical equipment manufacturing and sales | 638,740 | 638,740 | 21,273,122 | 36.26 | 582,011 | 24,782 | 7,325 | Note 1 | |
| DMC Components International, LLC | Orlando, USA | Sales agency | 24,304 | 24,304 | 300,000 | 30.00 | 7,516 | (1,233) | (370) | Note 2 | |
| DIVA Laboratories, Ltd. | DIVA Laboratories GmbH | Germany | Sales of monitor | 25,092 | 25,092 | - | 100.00 | 814 | (34) | (34) | - |
| DIVA Laboratories U.S., LLC | USA | Sales of monitor | 35,858 | 35,858 | - | 100.00 | 19,748 | (1,919) | (1,919) | - | |
| Diva Capital Inc. | Samoa | Reinvestment | 52,908 | 52,908 | - | 100.00 | 10,197 | 396 | 396 | Note 3 | |
| The Linden Group Corp. | USA | Sales of monitor | 30,015 | 30,015 | - | 19.00 | 2,050 | - | - | Notes 4 and 5 | |
| Diva Capital Inc. | Diva Holding Inc. | Samoa | Reinvestment | 52,598 | 52,598 | - | 100.00 | 10,314 | 396 | Note 6 | - |
Note 1: The difference between the profit and loss of the investee recognized based on the shareholding ratio in the current year and the investment gain or loss recognized in the current year is the effect of the fair value of the investee's assets being higher than the book value of the amortization.
Note 2: The carrying amount deducted the unrealized gain on downstream transactions of $225 thousand.
Note 3: The carrying amount deducted the unrealized gain on downstream transactions of $119 thousand.
Note 4: The carrying amount deducted the unrealized gain on downstream transactions of $1,507 thousand.
Note 5: DIVA Laboratories, Ltd. had accumulated $25,787 thousand of impairment loss on the investment in The Linden Group Corp. accounted for using the equity method.
Note 6: The profit or loss of the investee has been included in its investees. To avoid confusion, it is not expressed otherwise presented in these financial statements.
Note 7: The investment gain or loss between investees, the long-term equity investment of the investees, and the net worth of the equity of the investees were fully written off when the consolidated financial statements were prepared.
Data Image Corporation and Its Subsidiaries
Information on Investments in Mainland China
For the Three Months Ended March 31, 2026
(In Thousands of New Taiwan Dollars, Unless Stated Otherwise)
Table 5
| Investee Company | Main Businesses and Products | Paid-in capital | Method of Investment | Accumulated Outward Remittance for Investment from Taiwan at the Beginning of Year | Remittance of Funds | Accumulated Outward Remittance for Investment from Taiwan at the End of Period | Net Income (Loss) of the Investee | Ownership of Direct or Indirect Investment (%) | Investment Gain (Loss) (Note 1) | Carrying Amount on the End of Period (Note 1) | Accumulated Repatriation of Investment Income at the End of Period | |
| Outward | Inward | |||||||||||
| Data Image (Suzhou) Corporation | Manufacturing, processing, and sale of LCD touch modules and LCD modules | $ 534,081 (USD 16,300 thousand) | An investee in Mainland China through investment in the establishment of Data Image (MAURITIUS) Corporation in a third region | $ 511,884 (USD 15,654 thousand) | $ - | $ - | $ 511,884 (USD 15,654 thousand) | $ (2,832) (RMB (626) thousand) | 100% | $ (2,832) (RMB (626) thousand) | $ 563,652 (RMB 121,676 thousand) | $ - |
| Suzhou Diva Lab. Inc. | Medical equipment wholesale, import and export business | $ 52,643 (USD 1,725 thousand) | Diva Capital Inc., a 100% owned third region subsidiary, reinvested in a third region company Diva Holding Inc., and reinvested in a mainland China company | $ 52,643 (USD 1,725 thousand) | - | - | $ 52,643 (USD 1,725 thousand) | $ 399 (RMB 88 thousand) | 100% | $ 399 (RMB 88 thousand) | $ 10,284 (RMB 2,220 thousand) | - |
| Investor | Accumulated Outward Remittance for Investments in Mainland China at the End of the Period | Investment Amount Authorized by the Investment Commission, MOEA | Upper Limit on the Amount of Investments Stipulated by the Investment Commission, MOEA |
| The Company | USD 15,654 thousand | USD 16,952 thousand | $ 1,405,466 (Note 2) |
| DIVA Laboratories, Ltd. | USD 1,725 thousand | USD 2,000 thousand (Note 3) | $ 561,641 (Note 4) |
Note 1: It was recognized based on the financial statements reviewed by the parent company's CPAs in Taiwan for the same period.
Note 2: The calculation is based on the limit of 60% of the net worth, according to related regulations from the Investment Commission, MOEA.
Note 3: As of March 31, 2026, DIVA Laboratories, Ltd. had remitted an accumulated investment amount of US$1,725 thousand from Taiwan and an unexecuted investment amount of US$275 thousand.
Note 4: The calculation is based on a limit of 60% of the consolidated net value of DIVA Laboratories, Ltd., according to related regulations from the Investment Commission, MOEA.
Note 5: The investment gain or loss between investees, the long-term equity investment of the investees, and the net worth of the equity of the investees were fully written off when the consolidated financial statements were prepared.
^{}[] Data Image Corporation and Its Subsidiaries
^{}[] Significant Transactions with Investee Companies in Mainland China, Either Directly or Indirectly through a Third Party, and Their Prices, Payment Terms, and Unrealized Gains or Losses
^{}[] For the Three Months Ended March 31, 2026
^{}[] (In Thousands of New Taiwan Dollars,)
Table 6
| Investee Company | Transaction type | Purchases/sale | Price | Transaction Details | Notes/Accounts Receivable (Payable) | Unrealized (Gain) Loss | Note | |||
| Amount | % | Payment Terms | Comparison with Normal Transaction | Ending Balance | % | |||||
| Data Image (Suzhou) Corporation | Sales | $ 2,170 | - | Proceed in accordance with the agreed-upon price | To be determined subject to the capital status | To be determined subject to the capital status | $ - | - | $ - | - |
| Data Image (Suzhou) Corporation | Processing fee | 276,607 | 95% | Made at the general purchase price | To be determined subject to the capital status | To be determined subject to the capital status | (373,966) | 68% | - | (Note 1) |
Note 1: The Company sells raw materials and semi-finished products to Data Image (Suzhou) Corporation, and then it purchases partial finished products and semi-finished products from the company to sell to customers. As the processing is without imported materials, the related sales revenue and cost are expressed at a net amount.
Note 2: Transactions between Group have been fully written off when preparing the consolidated financial statements.
- 49 -